Search results for "breast neoplasms"

showing 10 items of 804 documents

Phase II Study of Bevacizumab in Combination with Trastuzumab and Capecitabine as First-Line Treatment for HER-2-positive Locally Recurrent or Metast…

2012

Abstract We report the first results from a phase II, open-label study designed to evaluate the efficacy and safety of bevacizumab in combination with trastuzumab and capecitabine as first-line therapy for human epidermal growth factor receptor (HER)-2-positive locally recurrent (LR) or metastatic breast cancer (MBC). Patients were aged ≥18 years with confirmed breast adenocarcinoma, measurable LR/MBC and documented HER-2-positive disease. Patients received bevacizumab (15 mg/kg on day 1) plus trastuzumab (8 mg/kg on day 1 of cycle 1, 6 mg/kg on day 1 of each subsequent cycle) plus capecitabine (1,000 mg/m2 twice daily, days 1–14) every 3 weeks until disease progression, unacceptable toxici…

AdultMaleOncologyCancer Researchmedicine.medical_specialtyBevacizumabReceptor ErbB-2HER-2-positivePhases of clinical researchBreast NeoplasmsAntibodies Monoclonal HumanizedDeoxycytidineDisease-Free SurvivalBreast Neoplasms MaleCapecitabineAcademia-Pharma IntersectTrastuzumabInternal medicineAntineoplastic Combined Chemotherapy ProtocolsmedicineClinical endpointHumansNeoplasm MetastasisAdverse effectskin and connective tissue diseasesCapecitabineAgedAged 80 and overbusiness.industryFirst-lineMiddle AgedTrastuzumabmedicine.diseaseMetastatic breast cancerMetastatic breast cancerBevacizumabOncologyFluorouracilFemaleFluorouracilNeoplasm Recurrence Localbusinessmedicine.drug
researchProduct

Clinical and pathologic characteristics of BRCA-positive and BRCA-negative male breast cancer patients: results from a collaborative multicenter stud…

2012

Recently, the number of studies on male breast cancer (MBC) has been increasing. However, as MBC is a rare disease there are difficulties to undertake studies to identify specific MBC subgroups. At present, it is still largely unknown whether BRCA-related breast cancer (BC) in men may display specific characteristics as it is for BRCA-related BC in women. To investigate the clinical–pathologic features of MBC in association with BRCA mutations we established a collaborative Italian Multicenter Study on MBC with the aim to recruit a large series of MBCs. A total of 382 MBCs, including 50 BRCA carriers, were collected from ten Italian Investigation Centres covering the whole country. In MBC p…

AdultMaleOncologyCancer Researchmedicine.medical_specialtyMolecular subtypesSettore MED/06 - Oncologia MedicaDNA Mutational AnalysisGenes BRCA2Genes BRCA1Breast Neoplasms MaleYoung Adultclinical-pathologic features; brca2; brca1; male breast cancer; molecular subtypesBreast cancerInternal medicinemedicineCarcinomaHumansYoung adultFamily historyskin and connective tissue diseasesBRCA1; BRCA2; Clinical-pathologic features; Male breast cancer; Molecular subtypesAgedAged 80 and overGynecologybusiness.industryCarcinoma Ductal BreastMiddle Agedmedicine.diseaseBRCA1BRCA2Male breast cancerItalyOncologyMale breast cancerImmunohistochemistryOvarian cancerbusinessClinical-pathologic featureRare disease
researchProduct

High prevalence of BRCA1 deletions in BRCAPRO-positive patients with high carrier probability.

2007

Mutation screening of the BRCA1 and BRCA2 genes in probands with familial breast/ovarian cancer has been greatly improved by the multiplex ligation-dependent probe amplification (MLPA) assay able to evidence gene rearrangements not detectable by standard screening methods. However, no criteria for selection of cases to be submitted to the MLPA test have been reported yet. We used the BRCAPro software for the selection of familial breast/ovarian cancer probands investigated with the MLPA approach after negative BRCA1/2 conventional mutation screening. One hundred and seventy-seven probands were investigated for germline BRCA1/2 mutations after assessment of genetic risk using BRCAPro. Proban…

AdultMaleOncologyProbandcongenital hereditary and neonatal diseases and abnormalitiesmedicine.medical_specialtyendocrine system diseasesBreast NeoplasmsGermlineBreast Neoplasms MaleGermline mutationBreast cancerRisk FactorsInternal medicinePrevalenceHumansMedicineGenetic Predisposition to DiseaseMultiplexMultiplex ligation-dependent probe amplificationskin and connective tissue diseasesAgedSequence DeletionOvarian NeoplasmsGeneticsBRCA1 Proteinbusiness.industryGenetic Carrier ScreeningProstatic NeoplasmsHematologyMiddle Agedmedicine.diseaseBRCA1 BRCA2 BRCAPro breast cancer MLPA ovarian cancerPedigreeOncologyMutation (genetic algorithm)FemalebusinessOvarian cancerSoftware
researchProduct

Apoptosis resistance in epithelial tumors is mediated by tumor-cell-derived interleukin-4

2008

We investigated the mechanisms involved in the resistance to cell death observed in epithelial cancers. Here, we identify that primary epithelial cancer cells from colon, breast and lung carcinomas express high levels of the antiapoptotic proteins PED, cFLIP, Bcl-xL and Bcl-2. These cancer cells produced interleukin-4 (IL-4), which amplified the expression levels of these antiapoptotic proteins and prevented cell death induced upon exposure to TRAIL or other drug agents. IL-4 blockade resulted in a significant decrease in the growth rate of epithelial cancer cells and sensitized them, both in vitro and in vivo, to apoptosis induction by TRAIL and chemotherapy via downregulation of the antia…

AdultMaleProgrammed cell deathLung NeoplasmsTime Factorsapoptosis interleukin-4 cancer stem cells cancer chemiotherapy cytokinesCASP8 and FADD-Like Apoptosis Regulating Proteinbcl-X ProteinAntineoplastic AgentsApoptosisBreast NeoplasmsBiologyTNF-Related Apoptosis-Inducing LigandTumor Cells CulturedmedicineHumansAutocrine signallingMolecular BiologyInterleukin 4AgedCell ProliferationSettore MED/04 - Patologia GeneraleCell DeathDose-Response Relationship DrugCell growthCarcinomaIntracellular Signaling Peptides and ProteinsAntibodies MonoclonalInterleukin-4 Receptor alpha SubunitCorrectionCancerCell BiologyMiddle AgedPhosphoproteinsmedicine.diseaseUp-RegulationCell biologyAutocrine CommunicationProto-Oncogene Proteins c-bcl-2Drug Resistance NeoplasmApoptosisColonic NeoplasmsCancer cellFemaleInterleukin-4Interleukin-4 Cancer stem cellsSignal transductionApoptosis Regulatory ProteinsSignal Transduction
researchProduct

Survey of autoantibody responses against tumor-associated antigens in thyroid cancer

2014

Background Autoantibodies against tumor-associated antigens (TAAs) have been shown to serve as highly specific serological biomarkers for the diagnosis of various solid cancers. Although the autoimmunity against thyroid tissue specific antigens has been studied extensively, so far, the autoantibody responses against common TAAs such as cancer-testis antigens (CTAs), mutated or differentiation antigens have not been comprehensively analyzed in patients with thyroid cancer. Objective The current study aims to characterize the frequency of autoantibody responses against common TAAs in patients with thyroid cancer and benign thyroid nodules. Methods A phage-displayed antigen microarray comprisi…

AdultMaleThyroid nodulesendocrine systemCancer ResearchLung Neoplasmsendocrine system diseasesBreast NeoplasmsYoung AdultBreast cancerAntigenAntigens NeoplasmBiomarkers TumorGeneticsmedicineHumansThyroid NeoplasmsLung cancerMelanomaThyroid cancerAgedAutoantibodiesAged 80 and overbusiness.industryThyroidAutoantibodyGeneral MedicineMiddle Agedmedicine.diseasemedicine.anatomical_structureOncologyCase-Control StudiesImmunologyCancer/testis antigensFemalebusinessCancer Biomarkers
researchProduct

Effect of Kernels Used for the Reconstruction of MDCT Datasets on the Semi-Automated Segmentation and Volumetry of Liver Lesions

2014

Purpose: To evaluate the effect of different reconstruction kernels on the semi-automated segmentation of liver lesions in MDCT. Materials and Methods: A total 62 liver lesions were measured by three independent radiologists with the semi-automated segmentation software Oncology-Prototype (Fraunhofer MEVIS, Siemens Healthcare, Germany) using MDCT datasets (3-mm slice thickness, 2-mm increment) reconstructed with standard, soft and detailed kernels (Philips B, A and D). To ensure objective measurements, only lesions with satisfactory initial segmentation were included, and manual correction was not used. The effective diameter and volume were recorded for each lesion. Segmentation in the sof…

AdultMalemedicine.medical_specialtyLung NeoplasmsInitial SeedAutomated segmentationBreast NeoplasmsTumor responseSensitivity and SpecificityMultidetector Computed TomographyImage Processing Computer-AssistedmedicineHumansRadiology Nuclear Medicine and imagingSegmentationTumor growthAgedMathematicsAged 80 and overbusiness.industryLiver NeoplasmsPattern recognitionSpiral Cone-Beam Computed TomographyGold standard (test)Middle AgedTumor BurdenEffective diameterLiverKernel (statistics)FemaleArtificial intelligenceRadiologyColorectal NeoplasmsbusinessSoftwareRöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren
researchProduct

Twins born after transplantation of ovarian cortical tissue and oocyte vitrification

2009

Objective To present a combination of ovarian tissue and oocyte cryopreservation as an effective strategy for achieving pregnancy in a breast cancer patient. Design Case report. Setting Tertiary care university-affiliated hospital, tissue bank, and infertility clinic. Patient(s) A 36-year-old patient diagnosed with atypical medullar breast cancer and negative for estrogen, P, and HER2 receptors underwent ovarian tissue cryopreservation before receiving chemotherapy and radiotherapy. Intervention(s) Laparoscopic ovarian cortex extraction, ovarian tissue cryopreservation, ovarian tissue thawing and transplantation, controlled ovarian stimulation (COS), oocyte retrieval, vitrification and IVF,…

AdultMalemedicine.medical_specialtyOvarian Cortexmedicine.medical_treatmentTwinsOocyte RetrievalBreast NeoplasmsGestational AgeFertilization in VitroBiologyCryopreservationEmbryo Culture TechniquesAndrologyOvulation InductionPregnancymedicineHumansOvarian tissue cryopreservationFertility preservationCryopreservationGynecologyOvaryInfant NewbornObstetrics and GynecologyOocyte cryopreservationEmbryo TransferEmbryo transferTransplantationFertilityTreatment OutcomeReproductive MedicineOocytesFemaleOvulation inductionFertility and Sterility
researchProduct

Metastatic instability at the proximal end of the femur

1994

A retrospective study was performed of the surgical treatment of metastatic lesions of the proximal femur in 50 patients. In 25 consecutive cases a megaprosthesis was implanted; compound plate osteosynthesis was performed in another 25 consecutive patients. Indications for surgical treatment were pathological fractures or, for prophylactic treatment, lesions of the femoral cortex exceeding 2.5 cm in diameter or affecting half the diameter of the bone or more. In all patients capable of walking preoperatively mobility was regained. Immediate full weight-bearing stability was obtained in all patients. Group analysis showed that the functional rating of the hip joint was unchanged, i.e., good …

AdultMalemedicine.medical_specialtyPalliative caremedicine.medical_treatmentBreast NeoplasmsProsthesisPostoperative ComplicationsOsseointegrationBone platemedicineHumansOrthopedics and Sports MedicineFemurReduction (orthopedic surgery)AgedRetrospective StudiesOsteosynthesisbusiness.industryFemoral NeoplasmsPalliative CareImplant failureGeneral MedicineMiddle AgedKidney NeoplasmsProsthesis FailureSurgeryFractures SpontaneousTreatment OutcomeOrthopedic surgeryFemaleSurgeryHip ProsthesisbusinessBone PlatesArchives of Orthopaedic and Trauma Surgery
researchProduct

Focal breast lesion characterization according to the BI-RADS US lexicon: role of a computer-aided decision-making support

2018

Objectives: to assess the diagnostic performance of a computer-guided decision- making software (S-Detect) in the US characterization of focal breast lesions (FBLs), according to the radiologist's experience. Materials and Methods: 300 FBLs (size: 2.6-47.2 mm; mean: 13.2 mm) in 255 patients (mean age: 51 years) were prospectively assessed in consensus according to BIRADS US lexicon by two experienced radiologists without and with S-Detect; to evaluate intra and inter-observer agreement, the same 300 FBLs were independently evaluated by two residents at baseline and after 3 months. Results: 120/300 (40%) FBLs were malignant, 2/300 (0.7%) high-risk and 178/300 (59.3%) benign. Experts review s…

AdultMalemedicine.medical_specialtySupport Vector MachineAdolescentdiagnosisBI-RADSBreast lesionneoplasmsBreast NeoplasmsBI-RADSLexiconComputer aidedBreast Neoplasms MaleDecision Support Techniques030218 nuclear medicine & medical imagingDiagnosis Differential03 medical and health sciences0302 clinical medicinePredictive Value of TestsmedicineHumansRadiology Nuclear Medicine and imagingDiagnosis Computer-AssistedBreastBI-RADS; breast; computer aided; diagnosis; neoplasms; ultrasonographyAgedNeuroradiologyUltrasonographyAged 80 and overmedicine.diagnostic_testbusiness.industryInterventional radiologyGeneral MedicineMiddle Aged030220 oncology & carcinogenesisComputer-aidedNeoplasmFemaleUltrasonography MammaryRadiologyUltrasonographybusinessSettore MED/36 - Diagnostica Per Immagini E RadioterapiaDiagnosi
researchProduct

Perceived barriers to and facilitators of being physically active during adjuvant cancer treatment

2016

The aim was to describe cancer patients' perceived barriers and facilitators of physical activity during adjuvant cancer treatment.Semi-structured focus group interviews were conducted with patients with breast cancer (n=9) and colorectal cancer (n=1) and prostate cancer (n=8) undergoing adjuvant cancer treatment. To capture perceived barriers and facilitators before starting treatment, individual interviews with women with breast cancer (n=5) were also conducted. 23 patients in total, were interviewed, and the transcribed interviews were analysed with qualitative content analysis.Three categories emerged: "Physical and emotional barriers"-addresses experiences of side-effects, co-morbid co…

AdultMalemedicine.medical_specialtymedicine.medical_treatmentPhysical activityAlternative medicineBreast NeoplasmsMotor ActivityInterviews as Topic03 medical and health sciences0302 clinical medicineNursingmedicineHumans030212 general & internal medicineExerciseQualitative ResearchAgedSwedenMotivationbusiness.industryProstatic NeoplasmsCancerGeneral MedicineFocus GroupsMiddle Agedmedicine.diseaseCombined Modality TherapyFocus groupSelf ConceptCancer treatmentChemotherapy Adjuvant030220 oncology & carcinogenesisFemalePerceptionRadiotherapy AdjuvantColorectal NeoplasmsbusinessAdjuvantPatient Education and Counseling
researchProduct